{"owner": "ArrayExpress Uploader", "pop_total": 0, "species": "human", "factors": [{"GSM566976": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "M_stage_IIIC"}}, {"GSM566976": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "M_stage_IIIC"}}, {"GSM566978": {"DISEASE STATE": "PR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIC"}}, {"GSM566978": {"DISEASE STATE": "PR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIC"}}, {"GSM566980": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "F_stage_IIIC"}}, {"GSM566980": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "F_stage_IIIC"}}, {"GSM566980": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "F_stage_IIIC"}}, {"GSM566983": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM566983": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM566983": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM566986": {"DISEASE STATE": "PD", "TREATMENT": "previous vaccine tx", "STAGE": "M_stage_IIIB"}}, {"GSM566986": {"DISEASE STATE": "PD", "TREATMENT": "previous vaccine tx", "STAGE": "M_stage_IIIB"}}, {"GSM566988": {"DISEASE STATE": "SD", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566988": {"DISEASE STATE": "SD", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566990": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566990": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566992": {"DISEASE STATE": "SD", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM566992": {"DISEASE STATE": "SD", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM566994": {"DISEASE STATE": "CR", "TREATMENT": "previous ILI", "STAGE": "F_stage_IIIC"}}, {"GSM566995": {"DISEASE STATE": "PD", "TREATMENT": "previous ILI", "STAGE": "F_stage_IIIB"}}, {"GSM566996": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIB"}}, {"GSM566990": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566990": {"DISEASE STATE": "CR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM566999": {"DISEASE STATE": "PR", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIB"}}, {"GSM567000": {"DISEASE STATE": "LTF/U", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIC"}}, {"GSM567000": {"DISEASE STATE": "LTF/U", "TREATMENT": "no previous ILI/ILP", "STAGE": "F_stage_IIIC"}}, {"GSM567002": {"DISEASE STATE": "PR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}, {"GSM567002": {"DISEASE STATE": "PR", "TREATMENT": "no previous ILI/ILP", "STAGE": "M_stage_IIIC"}}], "id": 3746, "ownerprofile_id": "arrayexpress_sid", "platform": 4, "summary_wrapped": "An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the...", "geo_gse_id": "E-GEOD-22968", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 3, "sample_count": 28, "tags": ["disease", "limb", "melanoma"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "phase-ii-trial-melphalan-ili-plus-adh-1-for-treatm", "geo_id_plat": "E-GEOD-22968_A-AFFY-44", "name": "Phase II trial melphalan ILI plus ADH-1 for treatment of in-transit extremity melanoma", "created": "Sep.15, 2014", "summary": "An evaluation of biopsies from patients with in-transit extremity melanoma who have been treated with ADH-1 followed by melphalan in the setting of isolated limb infusion Gene expression profiles were obtained from 28 lesions across 15 patients and evaluated for expression values that correlated with ADH-1 treatment given 4-8hrs prior to melphalan isolated limb infusion Chemotherapy response analysis:  complete response - CR; partial response - PR; stable disease - SD; progressive disease - PD; lost to follow-up - LTU/F ADH-1 treatment classification:  'pre' - lesions obtained prior to any treatment with ADH-1; 'post' - lesions obtained just prior to ILI with melphalan after 1 treatment with ADH-1; '2nd' - lesions obtained after a 2nd dose of ADH-1 given 8 days after melphalan ILI", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22968", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-22968/samples/"}